![]() |
![]() |
|
Holden Comprehensive Cancer Center
|
Hormone Replacement TherapyPeer Review Status: Holden Comprehensive Cancer Center, Cancer Information Service In July 2002, government scientists prematurely stopped a national study of hormone replacement therapy (HRT) because their findings, showed that long-term use of estrogen and progestin significantly increase women's risk of breast cancer, strokes and heart attacks. Doctors under the assumption that long-term use would prevent heart disease and brittle bones have prescribed hormone replacement therapy. Some women request HRT for the relief of menopausal symptoms, such as hot flashes. The scientists who stopped the hormone study were part of the Women's Health Initiative, funded by the National Institutes of Health (NIH). The NIH stopped the 16,600-woman study three years early. The women, who were taking the combination of estrogen and progestin on the study, were told to quit taking the pills. The NIH scientists also advised women not in the study, who take the HRT combination, to ask their doctors if they too, should quit taking the pills. The study results showed that in one year, for every 10,000 women taking the estrogen-progestin combination, there would be:
In other words, in two groups of 10,000 women each, one group taking HRT, the other group taking no hormones, 38 women taking the hormone combination would have breast cancer or a stroke, compared to 30 women who are not taking the HRT combination. And 37 women in the HRT group will have heart attacks compared to 30 women who do not take the hormones. What can women who are experiencing menopausal symptoms do to help relieve them?
|
||||
| Last modification date:
Mon Aug 7 13:09:58 2006
|
|||||